임상시험 관리 시스템(CTMS) 시장 : 구성요소별, 유형별, 제공 형태별, 최종사용자별 - 세계 예측(-2030년)

Clinical Trial Management System (CTMS) Market Size, Share, Forecast, & Trends Analysis by Component (Software, Service), Type (Enterprise, Site), Mode of Delivery (Web, Cloud, On-premise), End User (CRO, Pharmaceutical & Biotech) - Global Forecast to 2030

The clinical trial management system market is expected to grow at a CAGR of 13.5% from 2023 to 2030 to reach $3.59 billion by 2030.

Succeeding extensive secondary and primary research and in-depth analysis of the clinical trial management system market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. A surge in the number of clinical trials, increasing adoption of healthcare IT, and rising government support are the factors driving the market growth. Furthermore, increasing the adoption of AI-based CTMS will likely offer better growth opportunities for market expansion. Moreover, the growing trend of integrated CTMS solutions is expected to support market growth. However, the lack of skilled healthcare professionals to handle advanced digital solutions poses a major challenge to the growth of the CTMS market.

The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over four years (2020-2023). The key players operating in the global clinical trial management system (CTMS) market are Oracle Corporation (U.S.), SimpleTrials (U.S.), LABORATORY CORPORATION OF AMERICA HOLDINGS (U.S.), Wipro Limited (India), Advarra, Inc. (U.S.), RealTime Software Solutions, LLC (U.S.), Datatrak International, Inc. (U.S.), Clario (U.S.), Dassault Systemes (France), Veeva Systems Inc. (U.S.), PHARMASEAL (U.K.), MasterControl Inc. (U.S.), Calyx (U.S.), IQVIA HOLDINGS INC. (U.S.), and DSG, Inc. (U.S.) among others.

Based on component, the software segment is expected to account for the largest share of the market in 2023. The factors contributing to the largest share of the market are ease in establishing regulatory compliance in clinical trials, rising research & development expenditure, and effective management of clinical trials leading to increased adoption of the clinical trial management system (CTMS).

Based on type, the market is segmented into enterprise-based and site-based CTMS. The enterprise-based segment is expected to account for the largest share of the market in 2023, owing to advantages such as end-to-end insights into operational activities, reduction in cost and investment, and adaption to advanced processes due to control and connection within the organization.

Based on end user, the market is segmented into pharmaceutical & biotechnology companies, medical device companies, contract research organizations, and other end users. The contract research organization segment is expected to account for the largest share of the market in 2023. Companies tend to outsource their clinical trial operations as they are complex and require time and investment. The large share can be attributed to the increased outsourcing of clinical trials by various healthcare stakeholders, including pharmaceutical & biotechnology companies, medical device manufacturers, animal health companies, and a few academic institutes.

An in-depth analysis of the geographical scenario of the global clinical trial management system (CTMS) market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region.

Asia-Pacific is estimated to grow at the highest CAGR during the forecast period. Increasing outsourcing of clinical trials by major and minor stakeholders, the rising number of clinical trials in the region, and the availability of a large patient pool drive the demand for clinical trial management systems (CTMS).

Scope of the Report:

Global Clinical Trial Management System (CTMS) Market, by Component

• Software
• Service

Global Clinical Trial Management System (CTMS) Market, by Type

• Enterprise-based CTMS
• Site-based CTMS

Global Clinical Trial Management System (CTMS) Market, by Mode of Delivery

• Web-based CTMS
• Cloud-based CTMS
• On-premise CTMS

Global Clinical Trial Management System (CTMS) Market, by End User

• Contract Research Organizations (CROs)
• Pharmaceutical & Biotechnology Companies
• Medical Device Companies
• Other End Users

(Note: Other end users include hospitals, academic institutions, and animal health companies, among others)

Global Clinical Trial Management System (CTMS) Market, by Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe (RoE)
• Asia-Pacific (APAC)
  • China
  • Japan
  • India
  • Rest of APAC (RoAPAC)
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America (RoLATAM)
• Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• 1.1. Market Definition
• 1.2. Market Ecosystem
• 1.3. Currency
• 1.4. Key Stakeholders

2. Research Methodology

• 2.1. Research Process
• 2.2. Data Collection & Validation
  • 2.2.1. Secondary Research
  • 2.2.2. Primary Research
• 2.3. Market Assessment
  • 2.3.1. Market Size Estimation
    • 2.3.1.1. Bottom-up Approach
    • 2.3.1.2. Top-down Approach
    • 2.3.1.3. Growth Forecast
  • 2.3.2. Market Share Analysis
• 2.4. Assumptions for this Study
• 2.5. Limitations for the Study

3. Executive Summary

4. Market Insights

• 4.1. Introduction
• 4.2. Drivers
  • 4.2.1. Surge in Number of Clinical Trials
  • 4.2.2. Increasing Adoption of Healthcare IT Solutions
  • 4.2.3. Rising Government Support
• 4.3. Restraints
  • 4.3.1. Budget Constraints
  • 4.3.2. Concerns Over Data Privacy & Security
• 4.4. Opportunities
  • 4.4.1. Artificial Intelligence (AI) Based CTMS
• 4.5. Challenges
  • 4.5.1. Unavailability of Skilled Professionals
• 4.6. Impact of COVID-19 on the CTMS Market
• 4.7. Trend: Inclination of Companies Towards Integrated CTMS Solutions

5. Clinical Trial Management System (CTMS) Market, by Component

• 5.1. Introduction
• 5.2. Software
• 5.3. Service

6. Clinical Trial Management System (CTMS) Market, by Type

• 6.1. Introduction
• 6.2. Enterprise-based
• 6.3. Site-based

7. Clinical Trial Management System (CTMS) Market, by Mode of Delivery

• 7.1. Introduction
• 7.2. Web-based CTMS
• 7.3. Cloud-based CTMS
• 7.4. On-premise CTMS

8. Clinical Trial Management System (CTMS) Market, by End User

• 8.1. Introduction
• 8.2. Contract Research Organizations (CROs)
• 8.3. Pharmaceutical & Biotechnology Companies
• 8.4. Medical Device Companies
• 8.5. Other End Users

(Note: Other end users include hospitals, academic Institutions, and animal health companies, among others)

9. Clinical Trial Management System (CTMS) Market, by Geography

• 9.1. Introduction
• 9.2. North America
  • 9.2.1. U.S.
  • 9.2.2. Canada
• 9.3. Europe
  • 9.3.1. Germany
  • 9.3.2. France
  • 9.3.3. U.K.
  • 9.3.4. Italy
  • 9.3.5. Spain
  • 9.3.6. Rest of Europe (RoE)
• 9.4. Asia-Pacific
  • 9.4.1. Japan
  • 9.4.2. China
  • 9.4.3. India
  • 9.4.4. Rest of Asia-Pacific (RoAPAC)
• 9.5. Latin America
  • 9.5.1. Brazil
  • 9.5.2. Mexico
  • 9.5.3. Rest of Latin America
• 9.6. Middle East & Africa

10. Competitive Landscape

• 10.1. Introduction
• 10.2. Key Growth Strategies
• 10.3. Market Share Analysis (2022)

11. Company Profiles (Business Overview, Financial Snapshot, Product Portfolio, and Strategic Developments)

• 11.1. Oracle Corporation (U.S.)
• 11.2. SimpleTrials (U.S.)
• 11.3. LABORATORY CORPORATION OF AMERICA HOLDINGS (U.S.)
• 11.4. Wipro Limited (India)
• 11.5. Advarra, Inc. (U.S.)
• 11.6. RealTime Software Solutions, LLC (U.S.)
• 11.7. Datatrak International, Inc. (U.S.)
• 11.8. Clario (U.S.)
• 11.9. Dassault Systemes (France)
• 11.10. Veeva Systems Inc. (U.S.)
• 11.11. PHARMASEAL (U.K.)
• 11.12. MasterControl Inc. (U.S.)
• 11.13. Calyx (U.S.)
• 11.14. IQVIA HOLDINGS INC. (U.S.)
• 11.15. DSG, Inc. (U.S.)
• 11.16. Other Companies

12. Appendix

• 12.1. Questionnaire
• 12.2. Available Customization